Rabbit ATG for aplastic anaemia treatment: a backward step?

Another preparation of hATG (ATGAM) is manufactured in the USA, and has similar success rates to hATG (Lymphoglobulin) used in Europe,2 but its availability is restricted almost exclusively to the USA. rATG was previously used in patients not responding to a first course of immunosuppressive therapy...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet (British edition) 2011-11, Vol.378 (9806), p.1831-1833
1. Verfasser:	European Blood and Marrow Transplant Group, Severe Aplastic Anaemia Working Party
Format:	Artikel
Sprache:	eng
Schlagworte:	Anemia Anemia, Aplastic - diagnosis Anemia, Aplastic - mortality Anemia, Aplastic - therapy Animals Antilymphocyte serum Antilymphocyte Serum - adverse effects Antilymphocyte Serum - therapeutic use Blood transfusion Bone marrow Bone marrow transplantation Cyclosporine - adverse effects Cyclosporine - therapeutic use Globulins Hematology Histocompatibility antigen HLA Humans Immunity (Disease) Immunosuppressive agents Immunosuppressive Agents - therapeutic use Internal Medicine Medical research Patients Prognosis Rabbits Randomized Controlled Trials as Topic Research funding Response rates Risk Assessment Sensitivity and Specificity Severity of Illness Index Survival Analysis Thymocytes Transfusion Transplants & implants Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!